Research and Markets has announced the addition of the "Sepsis - Pipeline Insights, 2017" report to their offering.
Sepsis - Pipeline Insights, 2017 provides in depth insights on the pipeline drugs and their development activities around the Sepsis.
This report covers the product profiles in various stages of development including Discovery, Pre - clinical, IND, Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.
This report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Sepsis.
This report also assesses the Sepsis therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.
Key Topics Covered:
- Sepsis Overview
- Sepsis Disease Associated
- Sepsis Pipeline Therapeutics
- Sepsis Therapeutics under Development by Companies
- Sepsis Filed and Phase III Products
- Sepsis Phase II Products
- Sepsis Phase I and IND Filed Products
- Sepsis Discovery and Pre-Clinical Stage Products
- Drug Candidate Profiles
- Sepsis - Therapeutics Assessment
- Sepsis - Discontinued Products
- Sepsis - Dormant Products
- Companies Involved in Therapeutics Development for Sepsis
- Appendix
For more information about this report visit http://www.researchandmarkets.com/research/8zztsc/sepsis_pipeline
View source version on businesswire.com: http://www.businesswire.com/news/home/20170123005739/en/